Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) FCF Margin (2016 - 2025)

Historic FCF Margin for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to 9.96%.

  • Rockwell Medical's FCF Margin fell 243800.0% to 9.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.95%, marking a year-over-year decrease of 66100.0%. This contributed to the annual value of 3.14% for FY2024, which is 147400.0% up from last year.
  • Latest data reveals that Rockwell Medical reported FCF Margin of 9.96% as of Q3 2025, which was down 243800.0% from 10.53% recorded in Q2 2025.
  • Rockwell Medical's FCF Margin's 5-year high stood at 14.42% during Q3 2024, with a 5-year trough of 81.0% in Q1 2021.
  • In the last 5 years, Rockwell Medical's FCF Margin had a median value of 11.11% in 2024 and averaged 19.77%.
  • In the last 5 years, Rockwell Medical's FCF Margin plummeted by -384900bps in 2021 and then soared by 575800bps in 2022.
  • Rockwell Medical's FCF Margin (Quarter) stood at 59.61% in 2021, then soared by 97bps to 2.03% in 2022, then soared by 81bps to 0.39% in 2023, then surged by 590bps to 1.91% in 2024, then crashed by -623bps to 9.96% in 2025.
  • Its FCF Margin stands at 9.96% for Q3 2025, versus 10.53% for Q2 2025 and 18.84% for Q1 2025.